CY1118282T1 - UNIVERSITIES FOR THE TREATMENT OF DISEASE-RELATED DISEASES - RESTORATION - Google Patents
UNIVERSITIES FOR THE TREATMENT OF DISEASE-RELATED DISEASES - RESTORATIONInfo
- Publication number
- CY1118282T1 CY1118282T1 CY20161101112T CY161101112T CY1118282T1 CY 1118282 T1 CY1118282 T1 CY 1118282T1 CY 20161101112 T CY20161101112 T CY 20161101112T CY 161101112 T CY161101112 T CY 161101112T CY 1118282 T1 CY1118282 T1 CY 1118282T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- universities
- restoration
- disease
- related diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Abstract
Η παρούσα εφεύρεση αφορά σε ενώσεις του τύπου (I) που είναι χρήσιμες στη θεραπεία παθολογιών που συνδέονται με την ισχαιμία – επαναιμάτωση.The present invention relates to compounds of formula (I) which are useful in the treatment of pathologies associated with ischemia-reperfusion.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000062A ITFI20120062A1 (en) | 2012-03-21 | 2012-03-21 | COMPONENTS FOR THE TREATMENT OF DISEASES RELATED TO ISCHEMIA-REPERFUSION. |
| PCT/IB2013/052205 WO2013140348A1 (en) | 2012-03-21 | 2013-03-20 | Compounds for the treatment of ischemia-reperfusion- related diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1118282T1 true CY1118282T1 (en) | 2017-06-28 |
Family
ID=46147570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161101112T CY1118282T1 (en) | 2012-03-21 | 2016-11-03 | UNIVERSITIES FOR THE TREATMENT OF DISEASE-RELATED DISEASES - RESTORATION |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9932352B2 (en) |
| EP (1) | EP2855487B1 (en) |
| JP (2) | JP6382791B2 (en) |
| KR (2) | KR102181346B1 (en) |
| CN (1) | CN104395321B (en) |
| AU (2) | AU2013237021B2 (en) |
| CA (1) | CA2907652C (en) |
| CY (1) | CY1118282T1 (en) |
| DK (1) | DK2855487T3 (en) |
| EA (1) | EA033160B1 (en) |
| ES (1) | ES2601384T3 (en) |
| HR (1) | HRP20161436T1 (en) |
| HU (1) | HUE031535T2 (en) |
| IL (1) | IL234796B (en) |
| IN (1) | IN2014CH07744A (en) |
| IT (1) | ITFI20120062A1 (en) |
| LT (1) | LT2855487T (en) |
| ME (1) | ME02553B (en) |
| PL (1) | PL2855487T3 (en) |
| PT (1) | PT2855487T (en) |
| RS (1) | RS55337B1 (en) |
| SI (1) | SI2855487T1 (en) |
| SM (1) | SMT201700055B (en) |
| WO (1) | WO2013140348A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10531655B2 (en) | 2011-12-02 | 2020-01-14 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
| IT202000008125A1 (en) | 2020-04-16 | 2021-10-16 | Minerva Srl | 3-AZA-BICYCLE CARBOXYLIC ACIDS [3.2.1] OCTANE AND THEIR DERIVATIVES FOR USE IN THE TREATMENT OF INFLAMMATIONS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR75910B (en) | 1981-04-21 | 1984-08-02 | Delalande Sa | |
| EP1130022B1 (en) | 2000-02-29 | 2009-07-22 | Universita Degli Studi di Firenze | 3-Aza-6,8-dioxabicyclo[3.2.1]octanes and analogues and combinatorial libraries containing them |
| ITFI20020107A1 (en) * | 2002-06-19 | 2003-12-19 | Antonio Guarna | PHARMACEUTICAL COMPOSITIONS SUITABLE FOR USE IN THE TREATMENT OF DISEASES RELATED TO THE ACTION OF NEUTROFINS AND ACTIVE COMPOUNDS CONTAINED IN THEM |
| WO2004009588A1 (en) * | 2002-07-18 | 2004-01-29 | Pfizer Products Inc. | Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| WO2006015183A2 (en) * | 2004-07-30 | 2006-02-09 | Axonyx, Inc. | Pharmaceutical compositions for treating disorders of the skin |
| ATE540957T1 (en) * | 2008-11-25 | 2012-01-15 | Univ Firenze | BICYCLIC PEPTIDOMIMETICS INHIBITORS OF ASPARTYL PROTEASES FOR THE TREATMENT OF INFECTIOUS DISEASES |
-
2012
- 2012-03-21 IT IT000062A patent/ITFI20120062A1/en unknown
-
2013
- 2013-03-20 KR KR1020207012664A patent/KR102181346B1/en active IP Right Grant
- 2013-03-20 AU AU2013237021A patent/AU2013237021B2/en active Active
- 2013-03-20 CA CA2907652A patent/CA2907652C/en active Active
- 2013-03-20 CN CN201380026577.3A patent/CN104395321B/en active Active
- 2013-03-20 KR KR1020147029365A patent/KR20150014910A/en active Application Filing
- 2013-03-20 EP EP13721085.2A patent/EP2855487B1/en active Active
- 2013-03-20 US US14/387,015 patent/US9932352B2/en active Active
- 2013-03-20 HU HUE13721085A patent/HUE031535T2/en unknown
- 2013-03-20 RS RS20160926A patent/RS55337B1/en unknown
- 2013-03-20 DK DK13721085.2T patent/DK2855487T3/en active
- 2013-03-20 ES ES13721085.2T patent/ES2601384T3/en active Active
- 2013-03-20 WO PCT/IB2013/052205 patent/WO2013140348A1/en active Application Filing
- 2013-03-20 EA EA201401045A patent/EA033160B1/en unknown
- 2013-03-20 JP JP2015501034A patent/JP6382791B2/en active Active
- 2013-03-20 PT PT137210852T patent/PT2855487T/en unknown
- 2013-03-20 PL PL13721085T patent/PL2855487T3/en unknown
- 2013-03-20 SI SI201330411A patent/SI2855487T1/en unknown
- 2013-03-20 ME MEP-2016-251A patent/ME02553B/en unknown
- 2013-03-20 LT LTEP13721085.2T patent/LT2855487T/en unknown
-
2014
- 2014-09-22 IL IL234796A patent/IL234796B/en active IP Right Grant
- 2014-10-21 IN IN7744CH2014 patent/IN2014CH07744A/en unknown
-
2016
- 2016-11-02 HR HRP20161436TT patent/HRP20161436T1/en unknown
- 2016-11-03 CY CY20161101112T patent/CY1118282T1/en unknown
-
2017
- 2017-01-25 SM SM201700055T patent/SMT201700055B/en unknown
- 2017-11-21 AU AU2017265037A patent/AU2017265037B2/en active Active
- 2017-12-12 US US15/839,148 patent/US20180155363A1/en not_active Abandoned
-
2018
- 2018-06-27 JP JP2018122052A patent/JP2018168173A/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119105T1 (en) | DIPYRAZOLI PRODUCTS AS JAK SUSPENSIONS | |
| CY1119531T1 (en) | UNITS AND COMPOSITIONS FOR REGULATING THE EGFR ACTIVITY | |
| UY34602A (en) | Derivatives of benzimidazolyl- and imidazopyridinyl-methylamine? | |
| CY1118860T1 (en) | NEW DISASPYROCYCLOGANIA AND AZASPYROCYCALCANIA | |
| CY1119620T1 (en) | NEPRILYSIN Suspensions | |
| CY1118681T1 (en) | NEPRILYSIN Suspensions | |
| CL2016001733A1 (en) | Intermediate compounds for the preparation of piperidinone-derived compounds as mdm2 inhibitors for the treatment of cancer div. Sun. 3415-12. | |
| UY34780A (en) | VIRAL VECTORS FOR THE TREATMENT OF RETINIAN DYSTROPHY | |
| UY34472A (en) | MODIFIED DERIVATIVES OF 4-PHENYL-PYRIDINE | |
| UY34523A (en) | BETULINA DERIVATIVES | |
| UY34820A (en) | PIRROLO-PIRROLIDINONE TYPE COMPOUNDS | |
| CR20140510A (en) | NUCLEOSIDES OF URACILO SPYROOXETHANE | |
| UY34591A (en) | IMIDAZOPIRROLIDINONA COMPOUNDS | |
| EA201401054A1 (en) | N-CYCLILAMIDES AS NEMATOCIDES | |
| CR20130045A (en) | THERAPEUTIC COMPOUNDS | |
| CR20150271A (en) | PEPTIDES AS OXYCHOCINE AGONISTS | |
| UY34817A (en) | TIENOPIRIMIDINS | |
| CR20140468A (en) | DIACILGLICEROL ACILTRANSFERASA 2 INHIBITORS | |
| UY34825A (en) | Synthesis of heterocyclic compounds | |
| EA201691272A1 (en) | TETRAHYDROPYRIDOPIRASINES AS GPR6 MODULATORS | |
| CR20150470A (en) | DERIVATIVES OF TRIAZOLONA DE PIRIDINILO AND PIRIDINILO FUSIONADO | |
| UY34550A (en) | SUBSTITUTED BENCILPIRAZOLES | |
| BR112016029333A2 (en) | synthesis of polycyclic carbamoylpyridone compounds | |
| CY1120204T1 (en) | AMORPHIC SOLID SOLAR DISPOSAL FOR USE IN BRAND CANCER TREATMENT | |
| UY34654A (en) | BETA-SECRETASA INHIBITORS |